Back to Search Start Over

Heterogeneity of Large Cell Carcinoma of the Lung.

Authors :
Barbareschi, Mattia
Cantaloni, Chiara
Del Vescovo, Valerio
Cavazza, Alberto
Monica, Valentina
Carella, Rodolfo
Rossi, Giulio
Morelli, Luca
Cucino, Alberto
Silvestri, Massimo
Tirone, Giuseppe
Pelosi, Giuseppe
Graziano, Paolo
Papotti, Mauro
Palma, Paolo Dalla
Doglioni, Claudio
Denti, Michela Alessandra
Source :
American Journal of Clinical Pathology; Nov2011, Vol. 136 Issue 5, p773-782, 10p, 2 Color Photographs, 2 Charts, 1 Graph
Publication Year :
2011

Abstract

Large cell carcinomas (LCCs) of the lung are heterogeneous and may be of different cell lineages. We analyzed 56 surgically resected lung tumors classified as LCC on the basis of pure morphologic grounds, using a panel of immunophenotypic markers (adenocarcinoma [ADC]-specific, thyroid transcription factor-1, cytokeratin 7, and napsin A; squamous cell carcinoma [SQCC]-specific, p63, cytokeratin 5, desmocollin 3, and Δnp63) and the quantitative analysis of microRNA-205 (microRNA sample score [mRSS]). Based on immunoprofiles 19 (34%) of the cases were reclassified as ADC and 14 (25%) as SQCC; 23 (41%) of the cases were unclassifiable. Of these 23 cases, 18 were classified as ADC and 5 as SQCC according to the mRSS. Our data show that an extended panel of immunohistochemical markers can reclassify around 60% of LCCs as ADC or SQCC. However, a relevant percentage of LCCs may escape convincing immunohistochemical classification, and mRSS could be used for further typing, but its clinical relevance needs further confirmation. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00029173
Volume :
136
Issue :
5
Database :
Complementary Index
Journal :
American Journal of Clinical Pathology
Publication Type :
Academic Journal
Accession number :
70258337
Full Text :
https://doi.org/10.1309/AJCPYY79XAGRAYCJ